Dr. Amani Fawzi, MD

Dr. Fawzi practices at Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois.

Dr. Fawzi's NPI, 1558416313, was assigned on January 24, 2007. Dr. Fawzi holds Illinois license 036129455.

Dr. Fawzi's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD, at 259 E Erie St, Chicago, IL 60611.

Dr. Fawzi's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Fawzi to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Fawzi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fawzi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Fawzi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Fawzi is licensed in Illinois.

CMS data shows 1,624 Medicare services from Dr. Fawzi across 8 procedure codes in 2024, for 318 Medicare patients. Medicare paid $286,507 for them. Every service was in an office.

CMS counts 318 Medicare patients who saw Dr. Fawzi in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fawzi's median patient age at 72, with 61% women.

In 2024, Dr. Fawzi wrote 67 Medicare Part D claims for 24 patients. 85% of them were for generic drugs. CMS names the drug for 45 of them, across 2 drugs with 11 or more claims each, at $968 in total drug cost. In 2023, CMS named 62 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Fawzi for performance year 2024, reported through an alternative payment model (APM). Dr. Fawzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 114 papers to Dr. Fawzi, published from 2017 to 2025. 2019 was the busiest year, with 14. The most frequent topics are Tomography, Optical Coherence, Fluorescein Angiography and Retinal Vessels. Dr. Fawzi has published most often in Invest Ophthalmol Vis Sci. Dr. Fawzi's most frequent co-authors are Lee M. Jampol, MD, Alex C. Onishi and David Sarraf, MD.

CMS Open Payments shows 38 general payments to Dr. Fawzi from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Genentech, Inc. paid the most, $44,969. It also lists 15 research payments totaling $11,313 from 2023 to 2024.